News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
|
Followers
|
128
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
11574
|
|
Created
|
02/18/01
|
Type
|
Free
|
| Moderators | |||
Kallo, Inc. (KALO) leverages a suite of technologies to improve the quality and efficiency of care in the $6.3 trillion global healthcare industry. Offering centralized, congruent solutions that attend healthcare and business issues, the company addresses the needs of hospitals, ministries of health, physicians, and other healthcare organizations.
As a result of an expanding and aging population, coupled with an increasing number of people suffering from chronic diseases and lifestyle related conditions, healthcare expenditures continue to grow. Kallo is focused on introducing new healthcare technology that helps contain costs, enable better methods to monitor/treat medical conditions, and increase the reach of healthcare providers to remote areas.
The tailored solutions offered by Kallo complement existing infrastructure, workflows, and processes, increasing both uptime and productivity. The company’s suite of products complies with international, national, and regional standards, and its stringent quality control ensures repeatable, process-driven delivery for maximum performance.
Kallo’s executives and directors bring rich and diverse industry knowledge. Collectively, the management team reflects the strength of the company’s global network and the diversity of its global culture. The team’s entrepreneurship, passion, experience, and knowledge of healthcare enable Kallo to continually deliver higher standards.
|
|
Investment Highlights
Solutions
Powerful Portfolio of Technologies Address Global Healthcare Concerns
Kallo’s tailored solutions provide efficient delivery of healthcare services. The company’s technologies complement existing infrastructure, workflows and processes increasing uptime and productivity. All of Kallo’s clinical solutions are in compliance with international, national, and regional standards. The company’s stringent quality control ensures repeatable, process-driven delivery for maximum performance.
!ntegraat
!ntegraat enables any medical device to connect to any EMR, PACS, HIS, RIS, PIS or DI-r, providing a seamless flow of information and data that ensures clinicians have all the needed information to provide patients timely and effective healthcare.
Kallo MobileCare™
Kallo MobileCare™ is a comprehensive solution for remote and unreached communities. These mobile clinics are fully equipped with best-in-class medical devices and congruent information systems enabling the centralized coordination of resources and communications through Administration Centres.
The Clinical Command Centres provide support from medical specialists for complex cases through HL7, DICOM, HIPAA (among others) compliant information & telemedicine systems.
Kallo MobileCare™ is deployed with a full training program for ultimate adoption success incorporating medical and technical best practices from across the globe.
[To view animation of this mobile clinic experience, click here http://www.kalloinc.ca/mobileCareTM.aspx]
Kallo Rural-Care MRHDS (Modular Rural Healthcare Delivery Systems)
Kallo Rural-Care MRHDS are pre-fabricated, pre-tested, modular and project determined medical clinics. They are installed with the latest medical equipment from X-Ray and ultrasound to surgery, lab and pharmacy equipment. Based on project requirement, these clinics range from 1200 to 3800 square feet, and can be implemented in rural or disaster-struck areas in a week.
These medical clinics are prefabricated to include a patient exam room, operating room, imaging room, laboratory and dispensary. The staff quarters features a kitchenette, laundry and shower.
[To view animation of this mobile clinic experience, click here: http://www.kalloinc.ca/ruralcare.aspx.]
CygnaMed™
Globalization, inexpensive travel, high treatment costs, long wait times and lack of access to medical facilities have fuelled Medical Tourism to an approx. $25 billion industry. Producing stronger revenues than traditional tourism, Medical Tourism is attractive for many countries seeking to expand economic benefits.
oHealth
oHealth provides the infrastructure, technology, training and support to seamlessly integrate with any clinic, laboratory, specialty, hospital, repository or regional and national Health Information Access Layer (HIAL).
Keristää™
Keristää is software developed for the collection, integration and communication of clinical information in emergency conditions. The software enables close and instantaneous monitoring of infectious disease outbreaks. Keristää detects and identifies threats at various ports of entry and alerts the Centre for Disease Control/Ministry of Health. Utilizing this data, the software provides physicians the ability to ensure that treatment is based on latest CDC & WHO protocols.
Market Opportunity
Global Expenditures for Healthcare Above $6.3 Trillion, U.S. Leads Spending
The global healthcare system is increasingly overburdened with rising numbers of people suffering from chronic diseases and lifestyle related conditions. Due to an expanding and aging global population, healthcare expenditures continue to grow.
The U.S. devotes far more of its economy -- 17.6 percent of GDP in 2010 -- to health than any other country, according to the most recent report from the Organization for Economic Co-operation and Development (OECD).
As budgets tighten and costs rise, developments in healthcare technology help contain costs, contribute to the development of better methods to monitor/treat medical conditions, and increase the reach of healthcare providers to remote areas.
Kallo’s suite of products - including four copyrighted technologies - is positioned to serve this growing medical technology sector. Through innovation, telecommunication, technology and Total Quality Management, Kallo enables a seamless flow of information/data providing clinicians with all needed information to provide patients timely and effective healthcare.
In providing these technologies, the company has secured the opportunity to participate in several multi-billion dollar market segments.
Management Team
The members of Kallo’s management team have rich and diverse industry knowledge, delivering an unprecedented level of commitment and value to the company’s customers and shareholders. These remarkable people reflect the strength of Kallo’s global network and the diversity of its global culture. They have a special responsibility to act with integrity, accept accountability, insist on excellence, support innovation and lead by example.
JJohn Cecil - Chairman and CEO, Member of the Board of Directors
With a Bachelor’s degree in electrical engineering, a Master of Science degree in biomedical engineering and a Post Graduate Diploma in medical equipment technology, John Cecil has been in the healthcare industry for 26 years. He is responsible for the invention of the technology and procedure behind depth-of-anesthesia monitoring and non-invasive blood group testing, and was part of the research team that developed the electro-hydraulic shockwave lithotripter, laser lithotripter and transurethral microwave therapy systems. Following a distinguished career, holding such positions as vice president and director with major players in India including GE Medical Systems and Majoris Systems, Cecil immigrated to Canada in 2003 to continue his research and work on several products he is developing. Since then, he has served as director of healthcare with leading software services provider Satyam Computer Service Ltd. and senior healthcare solutions architect with Sun Microsystems. In April 2009, Cecil made the decision to devote his efforts exclusively to the development of a series of breakthrough technologies he has been working on, which are built for use in healthcare management.
Samuel R. Baker - Secretary and Legal Counsel, Member of the Board of Directors
Samuel R. Baker, Q.C., B.A., L.L.B., has been in the legal field for 48 years. He is a senior partner with Baker Law Firm, has provided legal counsel to numerous Fortune 500 and other multinational corporations, and is a founding member and Canadian representative to the Asia-Pacific Lawyers’ Association. He is also the director of the Canada-Netherlands and Canada-Finland Chambers of Commerce, and is the president of the Canada Scandinavian Business Association. His fellowships include: Teaching Fellow (Stanford 1962-63), Alberta Bar (1962), Ontario Bar (1966), and Fellow, Patent and Trademark Institute of Canada (1982). Baker is the author of books and articles on international transactions, joint ventures, technology transfers, establishing a business in Canada, among many other subjects.
Lloyd Chiotti – Member of the Board of Directors
Lloyd Chiotti holds an engineering degree and an MBA, both from the University of Toronto. He has worked with Enbridge Gas Distribution (formerly The Consumers Gas Company) for over 30 years. Over the course of his career he has held a number of senior management positions including director of Information Services and a number of regional general manager roles within operations. Most recently he was appointed to the newly formed position of director, distribution asset management, responsible for overseeing the development of Enbridge Gas Distribution’s Strategic Asset Plan. He is actively involved in the natural gas industry. He is currently the dhair of the Asset Management Task Force of the Canadian Gas Association and he is a member of the Distribution Working Committee of the International Gas Union. Throughout his career he has also served on the boards of a number of not-for-profit organizations including: president, Alternative Computer Training for the Disabled; chair, United Way of Peel Campaign 1992; chair of the Board, West Park Healthcare Centre Foundation; vice-chair of the board, Junior Achievement of Toronto; and chair of the board, Toronto Mendelssohn Choir.
Dr. Marion Lyver: Chief Medical Officer
Dr. Lyver is an emergency medicine specialist physician in the US and Canada, a seasoned healthcare / eHealth consultant and a Certified Professional in Healthcare Information and Management Systems (CPHIMS-CA - through COACH Canada and HIMSS US). She is an Associate Clinical Professor and PT Faculty member in the Department of Family Medicine at McMaster University and has a cross-faculty appointment with the Master's in eHealth program at McMaster. She earned her Bachelor of Science degree and her MD from Memorial University of Newfoundland and subsequent specialty certifications in Ontario and the US." Dr. Lyver is a well-respected and sought after physician and medical informatics expert. She has worked on a variety of successful projects for organizations such as Canada Health Infoway, the Canadian Institute for Health Information, Ontario Ministry of Health (MOHLTC), eHealth Ontario and for many national and international private sector firms. She is also an appointed or elected member of working groups or committees with several international organizations including ISO TC215 (health informatics standards), IHTSDO (clinical terminology) and the Royal College of Physicians & Surgeons (Canada) (Innovation & Technology sub-committee) and has served on the Board of COACH (Canada's Health Informatics association) and Canada Health Infoway's standards governance committees."
| Kallo, Inc. |
|
http://www.itdtrailers.com/email/index.html
We are very proud to have been awarded a contract for more than $50M from Kallo Inc, to manufacture Kallo Specialist Care Hospital & Mobile Care Clinics for the Republic of Guinea.
Kallo Inc. is an industry leader in global healthcare, improving the quality and efficiency of care with solutions for ministries of health, hospitals, physicians & other healthcare organizations.
To meet the demands of our new partnership with Kallo, and to continue delivering exceptional quality and service to our valued partners, ITD will be relocating to a new facility in the coming months.
Thank you for your continued partnership and for choosing ITD. We look forward to providing updates on our new facilities.
Sincerely,
Benny Di Franco
President
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
http://ghc-ca.com/ghana-mission-receives-boost-in-investor-confidence-as-high-commissioner-gariba-meets-the-leadership-of-potential-investors/
GHANA MISSION RECEIVES BOOST IN INVESTOR CONFIDENCE
AS HIGH COMMISSIONER GARIBA MEETS
THE LEADERSHIP OF POTENTIAL INVESTORS
The Ghana High Commission in Ottawa has stepped up efforts to increase Ghana’s visibility, and in particular, encourage investors in strategic sectors of the Economy of Ghana. This was manifested in separate events when two different potential investors at the Ghana High Commission in Ottawa.
On Wednesday October 5th, 2016, senior executives of the Desjardin International Development, a Quebec-based international development company paid a courtesy call on H.E. Dr. Sulley Gariba, to follow -up discussions on potential investment in Ghana’s agricultural financing sector. Their visit represents a follow-up on discussions between DiD and Ghana’s Minister of Finance, Hon Seth Terkpe, on prospects of collaboration in implementing Ghana’s EXIM Bank.
On Thursday October 6th, His Excellency Dr. Sulley Gariba received the leadership of Kallo Inc., a Canadian health services company, at the Ghana High Commission. Kallo Inc. is a Canadian and American based company, which is committed to offering a technologically advanced healthcare solutions to countries, particularly through rural healthcare. During the meeting, Mr. John Cecil, Chairman and President of Kallo indicated that the company has had long-standing experience working with the Ghana Health Service to combat Child and Maternal mortality in Ghana. He further noted that the company is currently poised to make substantial investments in undertaking innovative aspects of the President’s priority projects under the CHIPS Compounds initiative of the Government. On his part, His Excellency Dr. Sulley Gariba expressed hope that the proposed project when approved by the competent Ghanaian authorities, would facilitate better healthcare delivery that can easily be assessed by millions of Ghanaians in the rural areas and as a result, considerably reduce the cost and stress of travelling to far places to seek medical attention. Present at the meeting were the Mr. Lloyd Chiotti, Executive Vice President and Mr. Samuel R. Baker, Secretary and Member of the Board of Directors.
Mobile Clinics and Remote Access will Bring Medical Attention in Real Time
http://www.ibm.com/news/ca/en/2015/02/05/f692657d69299y50.html
